Topics

Sanofi and U.S. group Translate Bio to work on COVID-19 vaccine

02:41 EDT 27 Mar 2020 | Reuters

French healthcare company Sanofi Pasteur and U.S. company Translate Bio announced on Friday plans to collaborate on developing a vaccine to treat the coronavirus, which has killed thousands around the world.

Original Article: Sanofi and U.S. group Translate Bio to work on COVID-19 vaccine

NEXT ARTICLE

More From BioPortfolio on "Sanofi and U.S. group Translate Bio to work on COVID-19 vaccine"

Quick Search

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...